A rare case of paraneoplastic Guillain-Barré syndrome in a patient with endometrial cancer
  • Asif Mohamed Farook
    Department of Critical Care Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka
  • Dilshan Priyankara
    Department of Critical Care Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka
  • Chamali Aluwihare
    Department of Critical Care Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka
  • Anthony Mendis
    Department of Critical Care Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka

Keywords

Guillain-Barré syndrome, paraneoplastic, endometrial carcinoma

Abstract

Introduction: Guillain-Barré syndrome is an acute, inflammatory polyradiculoneuropathy of autoimmune aetiology. It is a rare disease seen in 1 in 100,000 person-years. Up to 20% of those affected develop severe disability; mortality in Guillain-Barré syndrome is 5%. Guillain-Barré, associated with many malignancies as a paraneoplastic phenomenon, has been reported – especially in haematological malignancies such as lymphoma and leukaemia. Solid tumours associated with paraneoplastic Guillain-Barré syndrome are breast and lung cancers. The association between paraneoplastic Guillain-Barré syndrome and gynaecological malignancies are rare, and only a handful of cases have been previously reported in gynaecological cancers.
Case description: We discuss a 65-year-old Sri Lankan female patient diagnosed with metastatic endometrial carcinoma who presented with paraneoplastic Guillain-Barré syndrome. The patient was treated appropriately and eventually recovered from her condition.
Conclusion: Paraneoplastic Guillain-Barré syndrome is a rare phenomenon that clinicians can easily miss, and it has rarely been described in gynaecological cancers. Our patient was diagnosed with this rare phenomenon. The timely recognition and prompt treatment of this potentially life-threatening condition with multiple complications is essential in managing patients with malignancies and neuropathy. Further studies on paraneoplastic Guillain-Barré syndrome are needed as cases may be underreported.

VIEW THE ENTIRE ARTICLE

References

  • Svarna A, Liontos M, Reppas G, Fiste O, Andrikopoulou A, Dimopoulos MA, et al. What to expect from paraneoplastic syndromes of the nervous system in uterine cancer: a review of the literature. Gynecol Oncol Rep 2023;45:101136.
  • Willison HJ. The immunobiology of Guillain-Barré syndromes. J Peripher Nerv Syst 2005;10:94–112.
  • Vallat JM, De Mascarel HA, Bordessoule D, Jauberteau MO, Tabaraud F, Gelot A, et al. Non-Hodgkin malignant lymphomas and peripheral neuropathies—13 cases. Brain 1995;118:1233–1245.
  • Vigliani MC, Magistrello M, Polo P, Mutani R, Chiò A. Piemonte and Valle d’Aosta Register for Guillain-Barré Syndrome. Risk of cancer in patients with Guillain-Barré syndrome (GBS). A population-based study. J Neurol 2004;25:321-326.
  • Tho LM, O’Leary CP, Horrocks I, Al-Ani A, Reed NS. Guillain-Barré syndrome occurring after adjuvant chemo-radiotherapy for endometrial cancer. Gynecol Oncol 2006;100:615–617.
  • Norman M, Elinder G, Finkel Y. Vincristine neuropathy and a Guillain-Barré syndrome: a case with acute lymphatic leukemia and quadriparesis. Eur J Haematol 1987;39:75–76.
  • Brzezinska BN, Higgins RV, Rungruang B. Guillain-Barré Syndrome in a patient with uterine adenocarcinoma undergoing treatment with immune-checkpoint inhibitor therapy: a case report and review of the literature. Gynecol Oncol Rep 2021;36:100739.

    • Views: 344
    HTML downloads: 105
    PDF downloads: 268

    Published: 2023-11-17
    Issue: 2023: Vol 10 No 12 (view)

    How to cite:
    1.
    Farook AM, Priyankara D, Aluwihare C, Mendis A. A rare case of paraneoplastic Guillain-Barré syndrome in a patient with endometrial cancer. EJCRIM 2023;10 doi:10.12890/2023_004077.